LATANOPROST
These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution, 0.005% Initial U.S. Approval: 1996
Approved
Approval ID
be74d517-7f73-a74c-e053-2a95a90a3819
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 26, 2021
Manufacturers
FDA
NuCare Pharmaceuticals,Inc.
DUNS: 010632300
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
LATANOPROST
PRODUCT DETAILS
NDC Product Code68071-2376
Application NumberANDA201786
Marketing CategoryC73584
Route of AdministrationOPHTHALMIC
Effective DateMarch 26, 2021
Generic NameLATANOPROST
INGREDIENTS (5)
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSInactive
Code: 22ADO53M6F
Classification: IACT
LATANOPROSTActive
Quantity: 50 ug in 1 mL
Code: 6Z5B6HVF6O
Classification: ACTIB
SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATEInactive
Code: 593YOG76RN
Classification: IACT